Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $481.0 million.

  • Teva Pharmaceutical Industries' Profit After Tax rose 27490.91% to $481.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year increase of 17072.32%. This contributed to the annual value of $1.4 billion for FY2025, which is 17238.39% up from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Profit After Tax is $481.0 million, which was up 27490.91% from $434.0 million recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Profit After Tax ranged from a high of $1.7 billion in Q4 2023 and a low of -$1.3 billion during Q4 2022
  • Over the past 5 years, Teva Pharmaceutical Industries' median Profit After Tax value was -$44.5 million (recorded in 2021), while the average stood at -$101.0 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 123690.48% in 2022, then soared by 27490.91% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Profit After Tax (Quarter) stood at -$152.0 million in 2021, then tumbled by 776.97% to -$1.3 billion in 2022, then soared by 227.31% to $1.7 billion in 2023, then plummeted by 116.21% to -$275.0 million in 2024, then soared by 274.91% to $481.0 million in 2025.
  • Its last three reported values are $481.0 million in Q4 2025, $434.0 million for Q3 2025, and $283.0 million during Q2 2025.